| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcus agalactiae | 44 | 2013 | 375 | 4.910 |
Why?
|
| Communicable Diseases, Emerging | 13 | 2019 | 157 | 3.300 |
Why?
|
| Streptococcal Infections | 29 | 2013 | 638 | 2.090 |
Why?
|
| Disease Outbreaks | 28 | 2022 | 1772 | 2.010 |
Why?
|
| Antigens, Surface | 20 | 2009 | 1663 | 1.960 |
Why?
|
| Population Surveillance | 11 | 2019 | 2616 | 1.480 |
Why?
|
| Bacterial Proteins | 27 | 2013 | 3849 | 1.310 |
Why?
|
| Internet | 10 | 2016 | 3063 | 1.120 |
Why?
|
| Electronic Mail | 4 | 2017 | 213 | 1.020 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 3 | 2014 | 459 | 0.970 |
Why?
|
| Antigens, Bacterial | 13 | 2008 | 1171 | 0.890 |
Why?
|
| Influenza, Human | 6 | 2022 | 1480 | 0.780 |
Why?
|
| Foodborne Diseases | 2 | 2020 | 39 | 0.780 |
Why?
|
| Glycosaminoglycans | 3 | 2008 | 624 | 0.690 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 7 | 2003 | 799 | 0.660 |
Why?
|
| Streptococcal Vaccines | 5 | 2008 | 43 | 0.650 |
Why?
|
| Epidemics | 4 | 2019 | 523 | 0.630 |
Why?
|
| Communicable Disease Control | 3 | 2019 | 857 | 0.590 |
Why?
|
| Sentinel Surveillance | 4 | 2023 | 281 | 0.540 |
Why?
|
| Vaccines | 3 | 2016 | 822 | 0.520 |
Why?
|
| Plant Diseases | 2 | 2014 | 150 | 0.510 |
Why?
|
| Information Services | 2 | 2006 | 244 | 0.500 |
Why?
|
| Public Opinion | 3 | 2020 | 477 | 0.470 |
Why?
|
| Antibodies, Bacterial | 13 | 2008 | 1470 | 0.440 |
Why?
|
| Immunization | 6 | 2016 | 1256 | 0.390 |
Why?
|
| Public Health | 8 | 2019 | 2603 | 0.380 |
Why?
|
| Communicable Diseases | 6 | 2017 | 880 | 0.380 |
Why?
|
| Vaccination | 7 | 2021 | 3278 | 0.370 |
Why?
|
| Massachusetts | 14 | 2023 | 8663 | 0.370 |
Why?
|
| Bacterial Translocation | 2 | 2007 | 73 | 0.370 |
Why?
|
| Public Health Informatics | 1 | 2011 | 110 | 0.370 |
Why?
|
| Polysaccharides, Bacterial | 6 | 2006 | 578 | 0.330 |
Why?
|
| Bacterial Vaccines | 6 | 1999 | 403 | 0.330 |
Why?
|
| Serotyping | 11 | 2014 | 338 | 0.330 |
Why?
|
| Genome, Viral | 3 | 2021 | 667 | 0.320 |
Why?
|
| Epithelial Cells | 7 | 2008 | 3690 | 0.320 |
Why?
|
| Integrin alpha1beta1 | 1 | 2007 | 8 | 0.320 |
Why?
|
| Vaccines, Conjugate | 7 | 2014 | 333 | 0.310 |
Why?
|
| Epidemiologic Methods | 1 | 2013 | 1365 | 0.310 |
Why?
|
| Dengue | 1 | 2011 | 256 | 0.310 |
Why?
|
| Pandemics | 5 | 2022 | 8387 | 0.300 |
Why?
|
| Immunity, Maternally-Acquired | 5 | 2007 | 118 | 0.300 |
Why?
|
| Genes, Bacterial | 6 | 2006 | 1079 | 0.290 |
Why?
|
| Mass Media | 3 | 2020 | 305 | 0.290 |
Why?
|
| Ebolavirus | 2 | 2022 | 263 | 0.290 |
Why?
|
| Information Storage and Retrieval | 2 | 2009 | 824 | 0.280 |
Why?
|
| Sequence Deletion | 3 | 2001 | 1526 | 0.270 |
Why?
|
| Pneumococcal Infections | 3 | 2015 | 497 | 0.270 |
Why?
|
| Zoonoses | 1 | 2006 | 185 | 0.270 |
Why?
|
| Cervix Uteri | 3 | 2007 | 590 | 0.260 |
Why?
|
| Penicillin Resistance | 2 | 2015 | 83 | 0.260 |
Why?
|
| Bacterial Capsules | 7 | 2008 | 251 | 0.240 |
Why?
|
| Virulence Factors | 2 | 2008 | 509 | 0.240 |
Why?
|
| Biosurveillance | 2 | 2014 | 17 | 0.240 |
Why?
|
| Tandem Repeat Sequences | 2 | 2001 | 185 | 0.230 |
Why?
|
| Bedding and Linens | 1 | 2023 | 41 | 0.220 |
Why?
|
| Humans | 97 | 2023 | 744220 | 0.220 |
Why?
|
| Health Services Research | 1 | 2010 | 1836 | 0.220 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2005 | 404 | 0.220 |
Why?
|
| Neglected Diseases | 2 | 2014 | 64 | 0.210 |
Why?
|
| Intensive Care Units | 2 | 2020 | 3680 | 0.210 |
Why?
|
| Penile Diseases | 1 | 2022 | 46 | 0.210 |
Why?
|
| Health Status Disparities | 1 | 2013 | 1797 | 0.200 |
Why?
|
| Streptococcus pneumoniae | 4 | 2015 | 714 | 0.200 |
Why?
|
| Rec A Recombinases | 1 | 2001 | 51 | 0.200 |
Why?
|
| Computer Systems | 2 | 2013 | 483 | 0.200 |
Why?
|
| Hepatitis E virus | 1 | 2022 | 71 | 0.200 |
Why?
|
| Skin Ulcer | 1 | 2022 | 120 | 0.190 |
Why?
|
| Hepatitis E | 1 | 2022 | 76 | 0.190 |
Why?
|
| Rectal Diseases | 1 | 2022 | 143 | 0.190 |
Why?
|
| Salmonella enteritidis | 1 | 2020 | 17 | 0.190 |
Why?
|
| Phylogeny | 5 | 2021 | 2803 | 0.190 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3132 | 0.180 |
Why?
|
| Mumps virus | 1 | 2020 | 24 | 0.180 |
Why?
|
| Molecular Sequence Data | 15 | 2013 | 18116 | 0.180 |
Why?
|
| Liver Abscess | 1 | 2000 | 82 | 0.180 |
Why?
|
| Crowding | 1 | 2021 | 145 | 0.180 |
Why?
|
| Quarantine | 1 | 2022 | 170 | 0.180 |
Why?
|
| Animals | 38 | 2021 | 168788 | 0.180 |
Why?
|
| Information Dissemination | 2 | 2006 | 1100 | 0.170 |
Why?
|
| Drosophila melanogaster | 1 | 2008 | 1708 | 0.170 |
Why?
|
| Mumps | 1 | 2020 | 64 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2013 | 3023 | 0.170 |
Why?
|
| Duodenoscopes | 1 | 2019 | 44 | 0.170 |
Why?
|
| Gene Expression Regulation, Bacterial | 3 | 2013 | 1123 | 0.170 |
Why?
|
| Monkeypox virus | 3 | 2023 | 48 | 0.160 |
Why?
|
| Animals, Newborn | 9 | 2008 | 2726 | 0.160 |
Why?
|
| Listeriosis | 1 | 2019 | 149 | 0.160 |
Why?
|
| Pregnancy Complications, Infectious | 6 | 2014 | 2026 | 0.160 |
Why?
|
| Equipment Contamination | 1 | 2019 | 185 | 0.150 |
Why?
|
| Plants | 2 | 2012 | 316 | 0.150 |
Why?
|
| Rabbits | 11 | 2006 | 4892 | 0.150 |
Why?
|
| Exanthema | 1 | 2022 | 501 | 0.150 |
Why?
|
| Mosaicism | 1 | 2000 | 441 | 0.150 |
Why?
|
| Streptococcus | 1 | 1997 | 197 | 0.150 |
Why?
|
| Klebsiella pneumoniae | 1 | 2019 | 251 | 0.150 |
Why?
|
| Multigene Family | 1 | 2000 | 1102 | 0.150 |
Why?
|
| Data Collection | 4 | 2019 | 3340 | 0.140 |
Why?
|
| Antigens, Viral | 1 | 2021 | 1035 | 0.140 |
Why?
|
| Viral Vaccines | 1 | 2002 | 636 | 0.140 |
Why?
|
| Politics | 2 | 2020 | 791 | 0.140 |
Why?
|
| Immunoglobulin G | 5 | 2007 | 4559 | 0.140 |
Why?
|
| Actins | 1 | 2004 | 2121 | 0.140 |
Why?
|
| Poliovirus Vaccines | 1 | 2016 | 18 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 7 | 2006 | 3871 | 0.140 |
Why?
|
| Sepsis | 3 | 2013 | 2593 | 0.140 |
Why?
|
| Respiratory Tract Infections | 1 | 2023 | 961 | 0.130 |
Why?
|
| Pregnancy | 13 | 2019 | 29142 | 0.130 |
Why?
|
| Phagocytosis | 7 | 2008 | 1538 | 0.130 |
Why?
|
| Genome, Bacterial | 3 | 2005 | 760 | 0.130 |
Why?
|
| Vagina | 2 | 2004 | 825 | 0.130 |
Why?
|
| Registries | 1 | 2010 | 8090 | 0.130 |
Why?
|
| Refugees | 1 | 2022 | 511 | 0.130 |
Why?
|
| Immunization, Passive | 4 | 1999 | 625 | 0.120 |
Why?
|
| Cholera | 2 | 2011 | 785 | 0.120 |
Why?
|
| Leishmaniasis | 1 | 2014 | 47 | 0.120 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2019 | 567 | 0.120 |
Why?
|
| Schools, Medical | 1 | 2021 | 878 | 0.120 |
Why?
|
| Bacterial Adhesion | 2 | 2007 | 316 | 0.120 |
Why?
|
| Protein Binding | 5 | 2009 | 9392 | 0.120 |
Why?
|
| Carrier Proteins | 4 | 2005 | 5021 | 0.120 |
Why?
|
| Emigrants and Immigrants | 1 | 2020 | 522 | 0.110 |
Why?
|
| Base Sequence | 9 | 2009 | 12801 | 0.110 |
Why?
|
| Fimbriae, Bacterial | 1 | 2013 | 138 | 0.110 |
Why?
|
| Female | 36 | 2023 | 380197 | 0.110 |
Why?
|
| RNA, Viral | 1 | 2021 | 2902 | 0.110 |
Why?
|
| Infant, Newborn | 12 | 2022 | 25618 | 0.110 |
Why?
|
| Uveitis | 1 | 2016 | 375 | 0.110 |
Why?
|
| Forecasting | 2 | 2019 | 2949 | 0.100 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2013 | 113 | 0.100 |
Why?
|
| Disease Notification | 1 | 2012 | 97 | 0.100 |
Why?
|
| Binding Sites | 4 | 2009 | 6116 | 0.100 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2012 | 137 | 0.100 |
Why?
|
| Mice | 21 | 2013 | 81178 | 0.100 |
Why?
|
| Epitopes | 3 | 1996 | 2571 | 0.100 |
Why?
|
| Government | 1 | 2012 | 165 | 0.100 |
Why?
|
| Virulence | 6 | 2013 | 1333 | 0.100 |
Why?
|
| Cloning, Molecular | 5 | 2001 | 4321 | 0.100 |
Why?
|
| Sputum | 1 | 2012 | 476 | 0.090 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2016 | 428 | 0.090 |
Why?
|
| Pneumococcal Vaccines | 1 | 2014 | 391 | 0.090 |
Why?
|
| Confidentiality | 1 | 2015 | 612 | 0.090 |
Why?
|
| Immune Sera | 4 | 1999 | 641 | 0.090 |
Why?
|
| Cell Line | 5 | 2008 | 15999 | 0.090 |
Why?
|
| Coronavirus | 1 | 2012 | 158 | 0.090 |
Why?
|
| Cell Wall | 1 | 2013 | 422 | 0.090 |
Why?
|
| United States | 11 | 2022 | 69867 | 0.090 |
Why?
|
| Microscopy, Confocal | 2 | 2007 | 1971 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 3 | 2007 | 3846 | 0.090 |
Why?
|
| Microbial Sensitivity Tests | 4 | 2020 | 1877 | 0.090 |
Why?
|
| Amino Acid Sequence | 7 | 2007 | 13817 | 0.090 |
Why?
|
| Contact Tracing | 2 | 2022 | 273 | 0.090 |
Why?
|
| Papillomavirus Vaccines | 1 | 2016 | 491 | 0.090 |
Why?
|
| Central America | 1 | 2009 | 68 | 0.090 |
Why?
|
| Fungi | 1 | 2012 | 327 | 0.090 |
Why?
|
| Private Sector | 1 | 2012 | 392 | 0.080 |
Why?
|
| Liver Transplantation | 1 | 2020 | 2118 | 0.080 |
Why?
|
| Seasons | 1 | 2015 | 1494 | 0.080 |
Why?
|
| Mycoses | 1 | 2012 | 376 | 0.080 |
Why?
|
| Bacteremia | 4 | 2015 | 962 | 0.080 |
Why?
|
| Molecular Epidemiology | 2 | 2021 | 468 | 0.080 |
Why?
|
| Amino Acid Motifs | 2 | 2009 | 936 | 0.080 |
Why?
|
| Travel | 2 | 2011 | 788 | 0.080 |
Why?
|
| Child | 7 | 2021 | 77679 | 0.080 |
Why?
|
| Animals, Outbred Strains | 2 | 2007 | 21 | 0.080 |
Why?
|
| Ecosystem | 1 | 2012 | 474 | 0.080 |
Why?
|
| Age Distribution | 1 | 2013 | 2903 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 4 | 2014 | 7179 | 0.080 |
Why?
|
| Electronic Health Records | 2 | 2015 | 4463 | 0.080 |
Why?
|
| Tuberculosis | 1 | 2020 | 1912 | 0.070 |
Why?
|
| Mexico | 1 | 2009 | 690 | 0.070 |
Why?
|
| Immunoglobulin A | 3 | 2007 | 992 | 0.070 |
Why?
|
| Pain | 1 | 2022 | 4987 | 0.070 |
Why?
|
| Antibodies, Viral | 3 | 2022 | 3176 | 0.070 |
Why?
|
| Bacterial Typing Techniques | 1 | 2007 | 256 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2007 | 1724 | 0.070 |
Why?
|
| Molecular Weight | 2 | 2000 | 2255 | 0.070 |
Why?
|
| Streptococcus pyogenes | 2 | 2005 | 289 | 0.070 |
Why?
|
| Critical Care | 2 | 2020 | 2644 | 0.070 |
Why?
|
| Subcellular Fractions | 2 | 2004 | 547 | 0.070 |
Why?
|
| Child, Preschool | 6 | 2021 | 40992 | 0.070 |
Why?
|
| Genital Diseases, Female | 1 | 2007 | 197 | 0.070 |
Why?
|
| Mass Screening | 1 | 2021 | 5252 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2000 | 2839 | 0.060 |
Why?
|
| Immunoglobulin M | 2 | 2007 | 1538 | 0.060 |
Why?
|
| Male | 16 | 2022 | 350027 | 0.060 |
Why?
|
| Crystallography, X-Ray | 2 | 2007 | 2012 | 0.060 |
Why?
|
| Vibrio cholerae | 1 | 2011 | 806 | 0.060 |
Why?
|
| Mutation | 5 | 2020 | 29784 | 0.060 |
Why?
|
| Species Specificity | 2 | 2006 | 2480 | 0.060 |
Why?
|
| Cross Reactions | 2 | 1997 | 841 | 0.060 |
Why?
|
| Chlorates | 1 | 2004 | 13 | 0.060 |
Why?
|
| Digitonin | 1 | 2004 | 27 | 0.060 |
Why?
|
| Social Class | 1 | 2013 | 1999 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 3 | 2001 | 6172 | 0.060 |
Why?
|
| Cytochalasin D | 1 | 2004 | 92 | 0.060 |
Why?
|
| Polysaccharide-Lyases | 1 | 2004 | 48 | 0.060 |
Why?
|
| Adolescent | 8 | 2021 | 85759 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2019 | 5102 | 0.060 |
Why?
|
| Diarrhea | 1 | 2011 | 1347 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 4 | 2020 | 4803 | 0.060 |
Why?
|
| Codon, Initiator | 1 | 2003 | 52 | 0.060 |
Why?
|
| Blotting, Western | 5 | 2001 | 5180 | 0.060 |
Why?
|
| Cytotoxins | 1 | 2004 | 153 | 0.060 |
Why?
|
| Lactic Acid | 1 | 2008 | 1132 | 0.060 |
Why?
|
| DNA, Bacterial | 4 | 2006 | 1467 | 0.060 |
Why?
|
| Transcription Initiation Site | 1 | 2003 | 196 | 0.060 |
Why?
|
| Schools | 2 | 2022 | 1433 | 0.060 |
Why?
|
| Comorbidity | 2 | 2014 | 10387 | 0.060 |
Why?
|
| Isoindoles | 1 | 2022 | 41 | 0.050 |
Why?
|
| Trifluridine | 1 | 2022 | 29 | 0.050 |
Why?
|
| Spleen | 2 | 2001 | 2361 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2013 | 7784 | 0.050 |
Why?
|
| Logistic Models | 2 | 2014 | 13409 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2004 | 5974 | 0.050 |
Why?
|
| Recombinant Proteins | 4 | 2008 | 6612 | 0.050 |
Why?
|
| Risk Factors | 4 | 2023 | 72280 | 0.050 |
Why?
|
| Conserved Sequence | 2 | 2009 | 1202 | 0.050 |
Why?
|
| Adult | 12 | 2022 | 214035 | 0.050 |
Why?
|
| Anus Diseases | 1 | 2022 | 59 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2014 | 7730 | 0.050 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2002 | 154 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 1792 | 0.050 |
Why?
|
| Congresses as Topic | 1 | 2006 | 764 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2003 | 1581 | 0.050 |
Why?
|
| Dominican Republic | 2 | 2011 | 76 | 0.050 |
Why?
|
| Communication | 1 | 2016 | 3749 | 0.050 |
Why?
|
| DNA Primers | 2 | 1996 | 2892 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2008 | 1782 | 0.050 |
Why?
|
| Point Mutation | 1 | 2007 | 1624 | 0.050 |
Why?
|
| Immunization Schedule | 1 | 2002 | 221 | 0.050 |
Why?
|
| Length of Stay | 1 | 2014 | 6308 | 0.050 |
Why?
|
| Boston | 2 | 2020 | 9311 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2022 | 402 | 0.050 |
Why?
|
| Suppuration | 1 | 2000 | 56 | 0.050 |
Why?
|
| Ulcer | 1 | 2022 | 209 | 0.050 |
Why?
|
| Cytosol | 1 | 2004 | 901 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 853 | 0.050 |
Why?
|
| Candidiasis, Invasive | 1 | 2020 | 22 | 0.050 |
Why?
|
| Authoritarianism | 1 | 2020 | 12 | 0.050 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2000 | 95 | 0.050 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 128 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2012 | 3591 | 0.050 |
Why?
|
| Immunoassay | 1 | 2004 | 752 | 0.050 |
Why?
|
| Sequence Alignment | 2 | 2005 | 2256 | 0.050 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2005 | 638 | 0.040 |
Why?
|
| RNA Interference | 1 | 2008 | 2890 | 0.040 |
Why?
|
| Sex Factors | 1 | 2013 | 10396 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2003 | 1547 | 0.040 |
Why?
|
| Candida | 1 | 2020 | 172 | 0.040 |
Why?
|
| Africa South of the Sahara | 1 | 2022 | 724 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 18027 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2004 | 1539 | 0.040 |
Why?
|
| Masks | 1 | 2021 | 197 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2002 | 645 | 0.040 |
Why?
|
| Tetanus Toxoid | 1 | 1999 | 193 | 0.040 |
Why?
|
| Lethal Dose 50 | 1 | 1998 | 77 | 0.040 |
Why?
|
| Colistin | 1 | 2019 | 47 | 0.040 |
Why?
|
| Food Handling | 1 | 2019 | 145 | 0.040 |
Why?
|
| Infant | 5 | 2021 | 35129 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2007 | 16687 | 0.040 |
Why?
|
| Gastrointestinal Diseases | 1 | 2007 | 1169 | 0.040 |
Why?
|
| Young Adult | 4 | 2021 | 56436 | 0.040 |
Why?
|
| Bacterial Toxins | 1 | 2004 | 931 | 0.040 |
Why?
|
| Enterococcus faecium | 1 | 1999 | 102 | 0.040 |
Why?
|
| Protein Transport | 1 | 2004 | 1989 | 0.040 |
Why?
|
| World Health Organization | 2 | 2016 | 1318 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 2088 | 0.040 |
Why?
|
| Biological Transport | 1 | 2002 | 2120 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 2 | 2014 | 2715 | 0.040 |
Why?
|
| Neonatal Screening | 1 | 2022 | 591 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 3 | 1992 | 9275 | 0.040 |
Why?
|
| Cross Infection | 1 | 2007 | 1416 | 0.040 |
Why?
|
| Enterococcus faecalis | 1 | 1999 | 251 | 0.040 |
Why?
|
| Age Factors | 1 | 2014 | 18367 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2007 | 5458 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2022 | 1402 | 0.040 |
Why?
|
| Rectum | 1 | 2022 | 904 | 0.040 |
Why?
|
| Software Design | 1 | 2017 | 176 | 0.040 |
Why?
|
| Listeria monocytogenes | 1 | 2019 | 250 | 0.040 |
Why?
|
| Immunochemistry | 1 | 1997 | 124 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2000 | 810 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 1997 | 256 | 0.040 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 1997 | 89 | 0.040 |
Why?
|
| Heparin | 1 | 2004 | 1637 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2021 | 694 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2018 | 53280 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2021 | 602 | 0.040 |
Why?
|
| Syndrome | 1 | 2023 | 3250 | 0.040 |
Why?
|
| Microfluidics | 1 | 2022 | 662 | 0.030 |
Why?
|
| Kinetics | 1 | 2004 | 6474 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4752 | 0.030 |
Why?
|
| Community Health Services | 1 | 2021 | 650 | 0.030 |
Why?
|
| Incidence | 3 | 2015 | 20945 | 0.030 |
Why?
|
| Antibody Affinity | 1 | 1996 | 254 | 0.030 |
Why?
|
| Trypsin | 1 | 1996 | 511 | 0.030 |
Why?
|
| Asthma | 1 | 2014 | 6011 | 0.030 |
Why?
|
| Prejudice | 1 | 2020 | 570 | 0.030 |
Why?
|
| Liberia | 1 | 2016 | 167 | 0.030 |
Why?
|
| Models, Animal | 1 | 2002 | 2171 | 0.030 |
Why?
|
| Vancomycin | 1 | 1999 | 501 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2020 | 730 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 4328 | 0.030 |
Why?
|
| Prions | 1 | 1997 | 181 | 0.030 |
Why?
|
| Information Systems | 1 | 2017 | 410 | 0.030 |
Why?
|
| Academies and Institutes | 1 | 2017 | 317 | 0.030 |
Why?
|
| Meningitis, Pneumococcal | 1 | 2015 | 42 | 0.030 |
Why?
|
| Pakistan | 1 | 2016 | 296 | 0.030 |
Why?
|
| Antibody Specificity | 2 | 2007 | 1095 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1998 | 2645 | 0.030 |
Why?
|
| Drainage | 1 | 2000 | 1141 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 1917 | 0.030 |
Why?
|
| Temperature | 1 | 2021 | 2206 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2005 | 1320 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2022 | 2309 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2004 | 3748 | 0.030 |
Why?
|
| Vaccines, Synthetic | 1 | 1997 | 634 | 0.030 |
Why?
|
| Leishmaniasis, Visceral | 1 | 2014 | 94 | 0.030 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2014 | 124 | 0.030 |
Why?
|
| Hospitals | 1 | 2007 | 3952 | 0.030 |
Why?
|
| Genomics | 1 | 2009 | 5722 | 0.030 |
Why?
|
| Rectal Neoplasms | 1 | 2022 | 1203 | 0.030 |
Why?
|
| Opsonin Proteins | 2 | 2005 | 150 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 14726 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2014 | 513 | 0.030 |
Why?
|
| France | 1 | 2014 | 517 | 0.030 |
Why?
|
| Middle Aged | 6 | 2021 | 213367 | 0.030 |
Why?
|
| Extinction, Biological | 1 | 2012 | 32 | 0.030 |
Why?
|
| Endopeptidases | 2 | 1999 | 772 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2020 | 1900 | 0.030 |
Why?
|
| Time Factors | 3 | 2016 | 40063 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2005 | 5096 | 0.030 |
Why?
|
| Middle East | 1 | 2012 | 219 | 0.030 |
Why?
|
| Heat-Shock Response | 1 | 2013 | 165 | 0.030 |
Why?
|
| Epidemiology | 1 | 2015 | 287 | 0.030 |
Why?
|
| Climate Change | 1 | 2017 | 418 | 0.030 |
Why?
|
| Penicillins | 1 | 2014 | 380 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2014 | 15538 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10949 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 950 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2017 | 1534 | 0.020 |
Why?
|
| Canada | 1 | 2016 | 2065 | 0.020 |
Why?
|
| Students | 1 | 2021 | 1654 | 0.020 |
Why?
|
| Fetal Blood | 2 | 2007 | 1317 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1996 | 3133 | 0.020 |
Why?
|
| Pneumonia, Bacterial | 1 | 2013 | 316 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2013 | 23404 | 0.020 |
Why?
|
| Antibodies, Neoplasm | 1 | 1991 | 286 | 0.020 |
Why?
|
| Lung | 1 | 2008 | 9852 | 0.020 |
Why?
|
| Vibrio cholerae O1 | 1 | 2011 | 242 | 0.020 |
Why?
|
| Haiti | 1 | 2011 | 553 | 0.020 |
Why?
|
| Cytokines | 1 | 2004 | 7326 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2017 | 2739 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2006 | 9647 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2009 | 12207 | 0.020 |
Why?
|
| Gene Expression | 2 | 2005 | 7799 | 0.020 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 1989 | 76 | 0.020 |
Why?
|
| Algorithms | 2 | 2023 | 13885 | 0.020 |
Why?
|
| Genetic Variation | 3 | 2007 | 6546 | 0.020 |
Why?
|
| Immunoblotting | 1 | 1991 | 1682 | 0.020 |
Why?
|
| Curriculum | 1 | 2021 | 3604 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 2011 | 593 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2000 | 5982 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2008 | 534 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2020 | 8321 | 0.020 |
Why?
|
| Immunodiffusion | 1 | 2006 | 163 | 0.020 |
Why?
|
| Escherichia coli | 2 | 1997 | 4220 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2007 | 365 | 0.020 |
Why?
|
| Health Personnel | 1 | 2020 | 3216 | 0.020 |
Why?
|
| Food Supply | 1 | 2012 | 524 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 813 | 0.020 |
Why?
|
| Health Surveys | 1 | 2016 | 4037 | 0.020 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2005 | 43 | 0.020 |
Why?
|
| Aged | 4 | 2021 | 163253 | 0.020 |
Why?
|
| Genotype | 1 | 2020 | 12956 | 0.020 |
Why?
|
| Feces | 1 | 2011 | 1402 | 0.020 |
Why?
|
| Educational Status | 1 | 2012 | 2539 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2005 | 587 | 0.010 |
Why?
|
| International Cooperation | 1 | 2010 | 1421 | 0.010 |
Why?
|
| Crystallization | 1 | 2005 | 524 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2008 | 2557 | 0.010 |
Why?
|
| Tomography, Optical Coherence | 1 | 2016 | 2657 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 5319 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 57768 | 0.010 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3239 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1991 | 6386 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2004 | 690 | 0.010 |
Why?
|
| Fetus | 1 | 2008 | 1880 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2022 | 77426 | 0.010 |
Why?
|
| Poverty | 1 | 2012 | 2660 | 0.010 |
Why?
|
| Acute Disease | 1 | 2011 | 7148 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1989 | 3203 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1997 | 7879 | 0.010 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 1999 | 52 | 0.010 |
Why?
|
| Hemolysin Proteins | 1 | 1999 | 113 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2007 | 21752 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2015 | 3311 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2007 | 2751 | 0.010 |
Why?
|
| Biomass | 1 | 1999 | 125 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1999 | 252 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2004 | 1200 | 0.010 |
Why?
|
| Peritoneum | 1 | 1999 | 228 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2009 | 5867 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 15070 | 0.010 |
Why?
|
| Biological Evolution | 1 | 2002 | 1076 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1999 | 865 | 0.010 |
Why?
|
| Epitope Mapping | 1 | 1997 | 311 | 0.010 |
Why?
|
| Immunodominant Epitopes | 1 | 1997 | 267 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 12961 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 1999 | 862 | 0.010 |
Why?
|
| Uterus | 1 | 1999 | 710 | 0.010 |
Why?
|
| Random Allocation | 1 | 1999 | 2427 | 0.010 |
Why?
|
| Hospitalization | 1 | 2014 | 10262 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1999 | 1372 | 0.010 |
Why?
|
| Phenotype | 1 | 1991 | 16365 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2002 | 3921 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 1991 | 5180 | 0.010 |
Why?
|
| Computational Biology | 1 | 2005 | 3523 | 0.010 |
Why?
|
| TATA Box | 1 | 1992 | 128 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 4419 | 0.010 |
Why?
|
| Neutrophils | 1 | 2005 | 3717 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 1993 | 331 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 1997 | 1849 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1992 | 878 | 0.010 |
Why?
|
| Rats | 1 | 2008 | 24273 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 1992 | 281 | 0.010 |
Why?
|
| Spain | 1 | 1993 | 465 | 0.010 |
Why?
|
| Gestational Age | 1 | 1999 | 3493 | 0.010 |
Why?
|
| Mycobacterium avium Complex | 1 | 1989 | 60 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 19227 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 1801 | 0.010 |
Why?
|
| Toxoplasma | 1 | 1989 | 150 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2014 | 63119 | 0.000 |
Why?
|
| DNA Transposable Elements | 1 | 1991 | 748 | 0.000 |
Why?
|
| Plasmids | 1 | 1991 | 2307 | 0.000 |
Why?
|
| Biopsy | 1 | 1997 | 6757 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 11368 | 0.000 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1989 | 2234 | 0.000 |
Why?
|
| Monocytes | 1 | 1989 | 2594 | 0.000 |
Why?
|
| Prevalence | 1 | 1993 | 15226 | 0.000 |
Why?
|
| Macrophages | 1 | 1989 | 5657 | 0.000 |
Why?
|
| Immunotherapy | 1 | 1989 | 4440 | 0.000 |
Why?
|
| Brain | 1 | 1997 | 26413 | 0.000 |
Why?
|